Paper22628
Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
Soroko FE and 4 others. J Pharm Pharmacol, 1977. Cited by 125 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent. Papers, record 22628. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22628
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bupropion hydrochloride ((+/-) alpha-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antidepressive Agents | Major topic |
| Propiophenones | Major topic |
| Amitriptyline | |
| Animals | |
| Behavior, Animal | |
| Brain Chemistry | |
| Cats | |
| Dextroamphetamine | |
| Dogs | |
| Guinea Pigs | |
| Hemodynamics | |
| In Vitro Techniques | |
| Lethal Dose 50 | |
| Methylphenidate | |
| Mice | |
| Monoamine Oxidase Inhibitors | |
| Muscle Contraction | |
| Muscle, Smooth | |
| Rabbits | |
| Rats | |
| Sleep | |
| Tetrabenazine |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 125 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,671,986 | Synthetic Cathinones: Epidemiology, Toxicity, Potential for Abuse, and Current Public Health Perspective. | Brain Sci | 2024 | https://conductscience.org/library/papers/38671986 | PubMed |
| 35,512,805 | Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine. | Drug Metab Dispos | 2023 | https://conductscience.org/library/papers/35512805 | PubMed |
| 35,457,736 | An Update on the Implications of New Psychoactive Substances in Public Health. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/35457736 | PubMed |
| 34,100,120 | An updated review on synthetic cathinones. | Arch Toxicol | 2021 | https://conductscience.org/library/papers/34100120 | PubMed |
| 32,249,347 | Designer drugs: mechanism of action and adverse effects. | Arch Toxicol | 2020 | https://conductscience.org/library/papers/32249347 | PubMed |
| 31,612,411 | The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression. | Mol Biol Rep | 2020 | https://conductscience.org/library/papers/31612411 | PubMed |
| 30,925,718 | Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30925718 | PubMed |
| 27,255,113 | Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers. | J Pharmacol Exp Ther | 2016 | https://conductscience.org/library/papers/27255113 | PubMed |
| 26,802,129 | Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In Vivo. | Drug Metab Dispos | 2016 | https://conductscience.org/library/papers/26802129 | PubMed |
| 25,337,378 | Microinfusion of bupropion inhibits putative GABAergic neuronal activity of the ventral tegmental area. | Basic Clin Neurosci | 2014 | https://conductscience.org/library/papers/25337378 | PubMed |
| 25,120,365 | A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder. | Neuropsychiatr Dis Treat | 2014 | https://conductscience.org/library/papers/25120365 | PubMed |
| 23,455,599 | Acute behavioural effects of bupropion and naltrexone, alone and in combination, in non-deprived male rats presented with palatable mash. | Psychopharmacology (Berl) | 2013 | https://conductscience.org/library/papers/23455599 | PubMed |
| 17,293,887 | Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. | Br J Pharmacol | 2007 | https://conductscience.org/library/papers/17293887 | PubMed |
| 8,099,801 | Dopamine and depression. | J Neural Transm Gen Sect | 1993 | https://conductscience.org/library/papers/8099801 | PubMed |
| 7,862,832 | Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers. | Psychopharmacology (Berl) | 1993 | https://conductscience.org/library/papers/7862832 | PubMed |
| 6,817,770 | The effects of bupropion, a new antidepressant drug, and diazepam, and their interaction in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6817770 | PubMed |
| 6,805,494 | Bupropion fails to affect plasma prolactin and growth hormone in normal subjects. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6805494 | PubMed |
| 6,804,243 | Pharmacokinetics of bupropion, a novel antidepressant agent, following oral administration to healthy subjects. | Eur J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6804243 | PubMed |
| 6,788,059 | Failure of bupropion to affect the response to tyramine in man. | Br J Clin Pharmacol | 1981 | https://conductscience.org/library/papers/6788059 | PubMed |
| 6,768,086 | Stimulus properties of antidepressants in the rat. | Psychopharmacology (Berl) | 1980 | https://conductscience.org/library/papers/6768086 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22628
GET https://conductscience.org/api/papers/v1/22628/cited_by?page=2